Quarterly Result7 Aug 2025, 05:42 pm
Metropolis Healthcare Reports 23% Revenue Growth to INR 386 Crore in Q1FY26; PAT Up 19% YoY
AI Summary
Metropolis Healthcare Limited, India's second-largest pathology laboratory chain, announced its unaudited consolidated financial results for the quarter ended June 30, 2025. The company reported a 23% YoY revenue growth to INR 386 Crore and a 19% YoY increase in Profit After Tax (PAT). Patient and test volumes grew by 11% and 12% YoY, respectively. Revenue per patient and test increased by 11% and 10% YoY. Specialty Diagnostics recorded the highest revenue growth at 32%. TruHealth wellness & illness bundled portfolio grew by 24%. The company's geographic footprint expanded, with North India's revenue contribution rising to 17% and Tier III cities registering a 17% revenue growth.
Key Highlights
- 23% YoY revenue growth to INR 386 Crore
- 19% YoY increase in PAT
- 11% YoY growth in patient and test volumes
- 32% YoY growth in Specialty Diagnostics
- 24% YoY growth in TruHealth wellness & illness bundled portfolio